A carregar...
Management of Overactive Bladder With Transdermal Oxybutynin
In clinical trials, transdermal oxybutynin (OXY-TDS) has shown comparable efficacy and improved tolerability when compared with conventional pharmacotherapy. Systemic anticholinergic adverse effects are comparable to those with placebo, most likely owing to avoidance of first-pass hepatic metabolism...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MedReviews, LLC
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1578546/ https://ncbi.nlm.nih.gov/pubmed/17043706 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|